nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—UGT1A9—Sorafenib—thyroid cancer	0.382	0.411	CbGbCtD
Ketobemidone—CYP2B6—Sorafenib—thyroid cancer	0.121	0.13	CbGbCtD
Ketobemidone—CYP2C8—Sorafenib—thyroid cancer	0.0916	0.0985	CbGbCtD
Ketobemidone—CYP2C19—Sorafenib—thyroid cancer	0.0769	0.0826	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—thyroid cancer	0.0734	0.0789	CbGbCtD
Ketobemidone—CYP2C9—Sorafenib—thyroid cancer	0.0639	0.0687	CbGbCtD
Ketobemidone—CYP3A4—Vandetanib—thyroid cancer	0.0616	0.0663	CbGbCtD
Ketobemidone—CYP3A4—Sorafenib—thyroid cancer	0.0372	0.0399	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—thyroid cancer	0.0225	0.0242	CbGbCtD
Ketobemidone—OPRM1—G alpha (i) signalling events—SST—thyroid cancer	0.000265	0.0038	CbGpPWpGaD
Ketobemidone—UGT1A9—PPARA activates gene expression—PPARG—thyroid cancer	0.000254	0.00365	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CALCB—thyroid cancer	0.000252	0.00362	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000249	0.00358	CbGpPWpGaD
Ketobemidone—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000249	0.00357	CbGpPWpGaD
Ketobemidone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000249	0.00357	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—TSHR—thyroid cancer	0.000244	0.0035	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000244	0.0035	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—PTCH1—thyroid cancer	0.000237	0.0034	CbGpPWpGaD
Ketobemidone—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000229	0.00329	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CALCB—thyroid cancer	0.000229	0.00328	CbGpPWpGaD
Ketobemidone—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000227	0.00326	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—SST—thyroid cancer	0.000217	0.00311	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000211	0.00303	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CALCA—thyroid cancer	0.000208	0.00299	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—PTCH1—thyroid cancer	0.000208	0.00298	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—MINPP1—thyroid cancer	0.000207	0.00297	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—TSHR—thyroid cancer	0.000206	0.00296	CbGpPWpGaD
Ketobemidone—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000198	0.00284	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000195	0.0028	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—SST—thyroid cancer	0.00019	0.00273	CbGpPWpGaD
Ketobemidone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000185	0.00265	CbGpPWpGaD
Ketobemidone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000184	0.00264	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CALCA—thyroid cancer	0.000183	0.00262	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CALCB—thyroid cancer	0.000182	0.00262	CbGpPWpGaD
Ketobemidone—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000176	0.00253	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NDUFA13—thyroid cancer	0.000176	0.00252	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—PTCH1—thyroid cancer	0.000175	0.00252	CbGpPWpGaD
Ketobemidone—CYP2B6—Biological oxidations—RXRA—thyroid cancer	0.000175	0.00251	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TRIM33—thyroid cancer	0.000173	0.00248	CbGpPWpGaD
Ketobemidone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000171	0.00246	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000168	0.00242	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CHST14—thyroid cancer	0.000165	0.00237	CbGpPWpGaD
Ketobemidone—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000161	0.00231	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—SST—thyroid cancer	0.00016	0.0023	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CALCB—thyroid cancer	0.00016	0.0023	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000157	0.00226	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—TSHR—thyroid cancer	0.000157	0.00226	CbGpPWpGaD
Ketobemidone—OPRM1—IL4-mediated signaling events—AKT1—thyroid cancer	0.000155	0.00223	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CALCA—thyroid cancer	0.000154	0.00222	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TRIM33—thyroid cancer	0.000152	0.00218	CbGpPWpGaD
Ketobemidone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00015	0.00215	CbGpPWpGaD
Ketobemidone—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000148	0.00213	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000143	0.00206	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—TSHR—thyroid cancer	0.000143	0.00205	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000141	0.00202	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000141	0.00202	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—TSHR—thyroid cancer	0.000138	0.00198	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CALCB—thyroid cancer	0.000135	0.00194	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CHST14—thyroid cancer	0.000135	0.00193	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—HPGD—thyroid cancer	0.000133	0.00191	CbGpPWpGaD
Ketobemidone—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000132	0.0019	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—HRAS—thyroid cancer	0.000131	0.00187	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MINPP1—thyroid cancer	0.000129	0.00185	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000128	0.00184	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TRIM33—thyroid cancer	0.000128	0.00184	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—TSHR—thyroid cancer	0.000125	0.0018	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000123	0.00177	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—SST—thyroid cancer	0.000122	0.00176	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PTCH1—thyroid cancer	0.000121	0.00174	CbGpPWpGaD
Ketobemidone—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000121	0.00173	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CALCA—thyroid cancer	0.000118	0.00169	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—TSHR—thyroid cancer	0.000117	0.00167	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TCF7L1—thyroid cancer	0.000115	0.00166	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—AKT1—thyroid cancer	0.000115	0.00166	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—SST—thyroid cancer	0.000111	0.0016	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NDUFA13—thyroid cancer	0.000109	0.00157	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MINPP1—thyroid cancer	0.000109	0.00156	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—HPGD—thyroid cancer	0.000109	0.00156	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000108	0.00155	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—SST—thyroid cancer	0.000107	0.00154	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CALCA—thyroid cancer	0.000107	0.00154	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PTCH1—thyroid cancer	0.000107	0.00153	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—TSHR—thyroid cancer	0.000106	0.00152	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000104	0.0015	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CALCA—thyroid cancer	0.000103	0.00148	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CHST14—thyroid cancer	0.000103	0.00148	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TCF7L1—thyroid cancer	0.000101	0.00145	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—SST—thyroid cancer	9.74e-05	0.0014	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MINPP1—thyroid cancer	9.71e-05	0.00139	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CDK1—thyroid cancer	9.68e-05	0.00139	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CALCA—thyroid cancer	9.38e-05	0.00135	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	9.25e-05	0.00133	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—SST—thyroid cancer	9.07e-05	0.0013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PTCH1—thyroid cancer	9e-05	0.00129	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MINPP1—thyroid cancer	8.86e-05	0.00127	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.81e-05	0.00126	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CALCA—thyroid cancer	8.73e-05	0.00125	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CHST14—thyroid cancer	8.7e-05	0.00125	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TCF7L1—thyroid cancer	8.55e-05	0.00123	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CDK1—thyroid cancer	8.49e-05	0.00122	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TSHR—thyroid cancer	8.44e-05	0.00121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PRKAR1A—thyroid cancer	8.3e-05	0.00119	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HPGD—thyroid cancer	8.28e-05	0.00119	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NDUFA13—thyroid cancer	8.26e-05	0.00119	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—SST—thyroid cancer	8.23e-05	0.00118	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—RXRA—thyroid cancer	7.95e-05	0.00114	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MEN1—thyroid cancer	7.94e-05	0.00114	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CALCA—thyroid cancer	7.93e-05	0.00114	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CHST14—thyroid cancer	7.77e-05	0.00111	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—TPR—thyroid cancer	7.65e-05	0.0011	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NDUFA13—thyroid cancer	7.53e-05	0.00108	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	7.53e-05	0.00108	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TSHR—thyroid cancer	7.4e-05	0.00106	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PRKAR1A—thyroid cancer	7.28e-05	0.00105	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTCH1—thyroid cancer	7.18e-05	0.00103	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CDK1—thyroid cancer	7.17e-05	0.00103	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CHST14—thyroid cancer	7.08e-05	0.00102	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HPGD—thyroid cancer	7.01e-05	0.00101	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MEN1—thyroid cancer	6.96e-05	0.000999	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.82e-05	0.000979	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SST—thyroid cancer	6.56e-05	0.000942	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CALCA—thyroid cancer	6.32e-05	0.000907	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	6.29e-05	0.000903	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HPGD—thyroid cancer	6.26e-05	0.000899	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TSHR—thyroid cancer	6.25e-05	0.000898	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TPR—thyroid cancer	6.24e-05	0.000895	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PRKAR1A—thyroid cancer	6.15e-05	0.000883	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PRKAR1A—thyroid cancer	6.13e-05	0.000881	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MEN1—thyroid cancer	5.88e-05	0.000844	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.84e-05	0.000839	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SST—thyroid cancer	5.76e-05	0.000826	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—SLC5A5—thyroid cancer	5.73e-05	0.000822	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDK1—thyroid cancer	5.72e-05	0.000821	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HPGD—thyroid cancer	5.71e-05	0.000819	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.69e-05	0.000817	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.56e-05	0.000798	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CALCA—thyroid cancer	5.54e-05	0.000795	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.37e-05	0.00077	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTCH1—thyroid cancer	5.32e-05	0.000764	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.08e-05	0.000729	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDK1—thyroid cancer	5.01e-05	0.00072	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.97e-05	0.000713	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SST—thyroid cancer	4.86e-05	0.000698	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—RXRA—thyroid cancer	4.81e-05	0.000691	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TPR—thyroid cancer	4.76e-05	0.000683	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CALCA—thyroid cancer	4.68e-05	0.000672	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	4.68e-05	0.000672	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.68e-05	0.000672	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CHST14—thyroid cancer	4.67e-05	0.00067	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—SLC5A5—thyroid cancer	4.67e-05	0.00067	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.63e-05	0.000665	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NRG1—thyroid cancer	4.59e-05	0.000659	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.37e-05	0.000628	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDK1—thyroid cancer	4.24e-05	0.000609	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TERT—thyroid cancer	4.12e-05	0.000592	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TPR—thyroid cancer	4.03e-05	0.000578	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NRG1—thyroid cancer	4.03e-05	0.000578	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.96e-05	0.000569	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HIF1A—thyroid cancer	3.94e-05	0.000566	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—RXRA—thyroid cancer	3.92e-05	0.000563	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.81e-05	0.000548	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HPGD—thyroid cancer	3.76e-05	0.00054	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TERT—thyroid cancer	3.61e-05	0.000519	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TPR—thyroid cancer	3.6e-05	0.000516	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.59e-05	0.000516	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SLC5A5—thyroid cancer	3.56e-05	0.000511	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.54e-05	0.000508	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—NRAS—thyroid cancer	3.47e-05	0.000499	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	3.46e-05	0.000496	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NRG1—thyroid cancer	3.4e-05	0.000488	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TPR—thyroid cancer	3.28e-05	0.000471	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—BRAF—thyroid cancer	3.26e-05	0.000469	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	3.23e-05	0.000463	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.21e-05	0.00046	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TERT—thyroid cancer	3.05e-05	0.000439	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	3.04e-05	0.000437	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PPARG—thyroid cancer	3.04e-05	0.000436	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	3.02e-05	0.000433	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—RXRA—thyroid cancer	2.99e-05	0.00043	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—KRAS—thyroid cancer	2.99e-05	0.000429	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.92e-05	0.00042	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HIF1A—thyroid cancer	2.92e-05	0.000419	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—BRAF—thyroid cancer	2.86e-05	0.000411	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.83e-05	0.000406	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.69e-05	0.000386	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	2.62e-05	0.000376	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—NRAS—thyroid cancer	2.57e-05	0.000369	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HRAS—thyroid cancer	2.54e-05	0.000365	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—RXRA—thyroid cancer	2.53e-05	0.000364	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.52e-05	0.000362	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—thyroid cancer	2.48e-05	0.000356	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—thyroid cancer	2.47e-05	0.000355	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.46e-05	0.000354	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.45e-05	0.000352	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—BRAF—thyroid cancer	2.42e-05	0.000347	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—thyroid cancer	2.39e-05	0.000343	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—thyroid cancer	2.38e-05	0.000342	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.3e-05	0.00033	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTEN—thyroid cancer	2.3e-05	0.00033	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—RXRA—thyroid cancer	2.26e-05	0.000325	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—thyroid cancer	2.24e-05	0.000322	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	2.23e-05	0.00032	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—thyroid cancer	2.21e-05	0.000318	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.2e-05	0.000316	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	2.17e-05	0.000311	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TPR—thyroid cancer	2.16e-05	0.00031	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.13e-05	0.000305	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—thyroid cancer	2.09e-05	0.0003	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTEN—thyroid cancer	2.08e-05	0.000299	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—RXRA—thyroid cancer	2.06e-05	0.000296	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NRAS—thyroid cancer	2.05e-05	0.000295	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTEN—thyroid cancer	2.02e-05	0.000289	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.01e-05	0.000288	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	1.97e-05	0.000282	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—thyroid cancer	1.95e-05	0.00028	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—thyroid cancer	1.89e-05	0.000271	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HRAS—thyroid cancer	1.88e-05	0.00027	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—thyroid cancer	1.83e-05	0.000263	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NRAS—thyroid cancer	1.8e-05	0.000258	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—thyroid cancer	1.77e-05	0.000253	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—thyroid cancer	1.77e-05	0.000253	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTEN—thyroid cancer	1.7e-05	0.000245	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTEN—thyroid cancer	1.7e-05	0.000244	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—thyroid cancer	1.66e-05	0.000239	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.62e-05	0.000232	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—thyroid cancer	1.6e-05	0.00023	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—thyroid cancer	1.57e-05	0.000225	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—thyroid cancer	1.55e-05	0.000222	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NRAS—thyroid cancer	1.52e-05	0.000218	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HRAS—thyroid cancer	1.5e-05	0.000215	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.49e-05	0.000213	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—thyroid cancer	1.43e-05	0.000205	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—thyroid cancer	1.38e-05	0.000198	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—RXRA—thyroid cancer	1.36e-05	0.000195	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—thyroid cancer	1.33e-05	0.00019	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HRAS—thyroid cancer	1.32e-05	0.000189	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—thyroid cancer	1.31e-05	0.000188	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—thyroid cancer	1.3e-05	0.000187	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTEN—thyroid cancer	1.3e-05	0.000186	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.26e-05	0.000181	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—thyroid cancer	1.2e-05	0.000172	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—thyroid cancer	1.16e-05	0.000167	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—thyroid cancer	1.16e-05	0.000167	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.12e-05	0.000161	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HRAS—thyroid cancer	1.11e-05	0.00016	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTEN—thyroid cancer	1.1e-05	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.02e-05	0.000147	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—thyroid cancer	9.82e-06	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTEN—thyroid cancer	9.79e-06	0.000141	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—thyroid cancer	9.79e-06	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTEN—thyroid cancer	8.93e-06	0.000128	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—thyroid cancer	8.59e-06	0.000123	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—thyroid cancer	7.47e-06	0.000107	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—thyroid cancer	6.75e-06	9.7e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—thyroid cancer	6.32e-06	9.08e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTEN—thyroid cancer	5.89e-06	8.46e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—thyroid cancer	5.64e-06	8.1e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—thyroid cancer	5.15e-06	7.39e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—thyroid cancer	3.39e-06	4.87e-05	CbGpPWpGaD
